ENDOXAN 1000 mg, powder for solution for injection bottle
Active ingredients: Cyclophosphamide hydrate, Anhydrous cyclophosphamide hydrate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for solution for injectionbottleintramusculaire;intraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ENDOXAN 1000 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 1000 mg
- Marketing authorisation holder
- BAXTER
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Apr 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69586327CIP75583704CIP133400955837046Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CYCLOPHOSPHAMIDEpoudre | 1069,00 mg · un flacon | SA |
| CYCLOPHOSPHAMIDE ANHYDREpoudre | 1000,00 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.